February 18, 2020
MSD on February 17 rolled out its anti-HIV treatment Pifeltro (doravirine) in Japan, the company said the same day. A novel non-nucleoside reverse transcriptase inhibitor (NNRTI) Pifeltro is indicated for the treatment of HIV-1 infection in combination with two nucleoside...read more